Home » Topics » BioWorld Science

BioWorld Science
RSS

Vion prepares more active prodrug of beta-L-FD4C

Jan. 27, 1998

AtheroGenics initiates phase I testing for new cardiovascular drug

Jan. 27, 1998

Mentor obtains marketing rights to new cancer therapeutic from Intracel

Jan. 27, 1998

New ET antagonists from Merck KGaA bearing a benzothiadiazole functionality

Jan. 27, 1998

First pivotal trial of lisofylline completed

Jan. 27, 1998

Progenitor and Affymetrix collaborate on asthma research

Jan. 27, 1998

New bacterial genomics company established by Theratechnologies

Jan. 27, 1998

New antimigraine combination addresses both headache and vomiting

Jan. 27, 1998

U.K. launch for Posicor

Jan. 27, 1998

Wyeth-Ayerst licenses PEPCK-modulating compounds

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...